Trial Condition(s):

Androgens (deficiency), Male

Efficacy and safety of Testogel® in men with partial androgen deficiency of aging males (PADAM)

Bayer Identifier:

91297

ClinicalTrials.gov Identifier:

NCT00185198

EudraCT Number:

2004-001545-15

Study Completed

Trial Purpose

The purpose of this study is to investigate the effect of a testosterone replacement therapy called Testogel in men with PADAM. The effects on body composition (lean, fat and bone) and other symptoms of PADAM and safety will be studied.

Inclusion Criteria
- Symptomatic hypogonadism
 - Willing to avoid significant change in the pattern of physical exercise and lifestyle for the duration of the study
Exclusion Criteria
- Patients with any contraindication for testosterone use

Trial Summary

Enrollment Goal
363
Trial Dates
black-arrow
Phase
3
Could I receive a placebo?
Yes
Products
Testogel (Testosterone, BAYV001915)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Wien, Austria, 1021

Status
Completed
 
Locations

Investigative Site

Barcelona, Spain, 08025

Status
Completed
 
Locations

Investigative Site

Tampere, Finland, 33521

Status
Completed
 
Locations

Investigative Site

London, United Kingdom, NW3 2QG

Status
Completed
 
Locations

Investigative Site

Dublin, Ireland

Status
Completed
 
Locations

Investigative Site

Roma, Italy, 00168

Status
Completed
 
Locations

Investigative Site

Salzburg, Austria, 5020

Status
Completed
 
Locations

Investigative Site

Oulu, Finland, 90100

Status
Completed
 
Locations

Investigative Site

Goteborg, Sweden, 41346

Status
Completed
 
Locations

Investigative Site

Innsbruck, Austria, 6020

Status
Completed
 
Locations

Investigative Site

Madrid, Spain, 28007

Status
Completed
 
Locations

Investigative Site

Helsinki, Finland, 00260

Status
Completed
 
Locations

Investigative Site

Milano, Italy, 20123

Status
Completed
 
Locations

Investigative Site

Malmo, Sweden, 20502

Status
Completed
 
Locations

Investigative Site

Leipzig, Germany, 04103

Status
Completed
 
Locations

Investigative Site

Wigan, United Kingdom, WN1 1XX

Status
Completed
 
Locations

Investigative Site

Halle, Germany, 06112

Status
Completed
 
Locations

Investigative Site

Stockholm, Sweden, 14186

Status
Completed
 
Locations

Investigative Site

Reading, United Kingdom, RG2 7AG

Status
Completed
 
Locations

Investigative Site

Bonn, Germany, 53105

Status
Completed
 
Locations

Investigative Site

Sheffield, United Kingdom, S5 7AU

Status
Completed
 
Locations

Investigative Site

Graz, Austria, 8036

Status
Completed
 
Locations

Investigative Site

London, United Kingdom, EC1A 7BE

Status
Completed
 
Locations

Investigative Site

Napoli, Italy, 80131

Status
Completed
 
Locations

Investigative Site

Magdeburg, Germany, 39310

Status
Completed
 
Locations

Investigative Site

Dresden, Germany, 01067

Status
Completed
 
Locations

Investigative Site

Cardiff, United Kingdom, CF14 5GJ

Status
Completed
 
Locations

Investigative Site

Roma, Italy, 00186

Status
Completed
 
Locations

Investigative Site

Hospitalet de Llobregat, Spain, 08907

Status
Completed
 
Locations

Investigative Site

Wien, Austria, 1090

Status
Completed
 

Trial Design